Changes in the pharmaceutical industry may be driving companies to prescription pharmaceutical drugs where demand is stronger, according to a report from market research firm Kalorama Information.    “Reliance on blockbuster drugs is all but over, causing a shift of focus for many drug research and development entities,” said Bruce Carlson, publisher of Kalorama Information.  “By focusing on cosmetic medications, many manufacturers are realizing less scrutiny from the FDA and a...